Cardiolipin IgM ELISA

Category Name

Autoimmune Disorders

Method

ELISA

Principle

ELISA

Controls Standards

Positive, Negative and Calibrator

Sensitivity

Not available

Sample

100 µl

Runtime

50 Minutes

Wavelength

450 nm

Safety

Please refer to MSDS

Shelflife

18 Months

Cardiolipin IgM ELISA Package Insert

Cardiolipin IgM ELISA MSDS

INTENDED USE
The Calbiotech anti-Cardiolipin (aCL) IgM ELISA Kit is intended for the detection of IgM antibody to Cardiolipin in human serum and plasma.

SUMMARY AND EXPLANATION

Measurement of IgG, IgM and IgA cardiolipin autoantibodies (aCL) by EIA is the standard procedure for the detection of antiphospholipid antibodies (aPL) in patients with suspected antiphospholipid syndrome (APS).High aCL concentrations are associated with increased risk of venous and arterial thrombosis, recurrent pregnancy loss and thrombocytopenia. Patients with the anti-cardiolipin syndrome have one of the above clinical features and have antibodies to cardiolipin and/or a positive lupus anticoagulant test. The antibodies present to cardiolipin may be of the IgG, IgA, IgM isotypes. Testing for the various antibody isotypes to cardiolipin aid in diagnosis of the anti-phospholipid syndrome in patients with SLE or lupus-like disorders. Binding of aCL to CL in patients with autoimmune diseases is dependent on the presence of the cofactor beta-2-glycoprotein I (beta₂-GPI); this binding is independent of beta-2-GPI in patients with infectious diseases (e.g., syphilis, tuberculosis). Recognition of the role of beta-2-GPI in the binding of aCL led to development of assay for direct measurement of beta-2-GPI autoantibodies using beta-2-GPI as antigen,allowing a clear distinction between beta-2-GPI autoantibodies and those that bind to CL alone.

PRINCIPLE OF THE TEST

Diluted patient serum (serum diluent contains sorbent to remove Rheumatoid Factor and human IgG interference) is added to wells coated with purified aCL antigen. aCL specific IgM antibody, if present, binds to the antigen. All unbound materials are washed away and the enzyme conjugate is added to bind to the antibody-antigen complex, if present. Excess enzyme conjugate is washed off and substrate is added. The plate is incubated to allow the hydrolysis of the substrate by the enzyme. The intensity of the color generated is proportional to the amount of specific IgM antibody in the sample.